Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Choroidal Morphology Changes After Aflibercept Therapy in Pachychoroid Neovasculopathy

NCT05662410 is registered in ClinicalTrials.gov with Kim's Eye Hospital as lead sponsor.

NCT NCT05662410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05662410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Choroidal Morphology Changes After Aflibercept Therapy in Pachychoroid Neovasculopathy
Lead sponsor
Kim's Eye Hospital
Phase
Phase 4
Overall status
Completed
Start date
December 26, 2022
Completion date
May 26, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pachychoroid neovasculopathy